Sollfrank L - Search Results

1

Panniculitis Under Successful Targeted Inhibition of the MAPK/ERK Signaling Pathway in a Patient With BRAF V600E-mutated Spindle Cell Oncocytoma of the Pituitary Gland.

Sollfrank L, Lettmaier S, Erdmann M, Uslu U. Sollfrank L, et al. Anticancer Res. 2019 Jul;39(7):3955-3959. doi: 10.21873/anticanres.13549. Anticancer Res. 2019. PMID: 31262927

2

Expression of recombinant surfactant protein SFTA3 in the human kidney cell line HEK 293T.

Schröder H, Fischer R, Sollfrank L, Paulsen F, Bräuer L, Schicht M. Schröder H, et al. Among authors: sollfrank l. Ann Anat. 2017 May;211:149-157. doi: 10.1016/j.aanat.2017.01.005. Epub 2017 Feb 3. Ann Anat. 2017. PMID: 28163207

3

Impact of off-label use regulations on patient care in dermatology - a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout Germany.

Werner RN, Pennitz A, Eisert L, Schmidle P, Zink A, Abraham S, Schäkel K, Wolff I, Goebeler M, Plange J, Sollfrank L, Zielbauer S, Koll P, Amschler K, Müller V, Nast A. Werner RN, et al. Among authors: sollfrank l. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2241-2249. doi: 10.1111/jdv.18357. Epub 2022 Jul 7. J Eur Acad Dermatol Venereol. 2022. PMID: 35737866

4

Corrigendum to "Recombinant expression of surfactant protein H (SFTA3) in Escherichia coli" [Ann. Anat. 208C (2016) 129-134].

Schröder H, Sollfrank L, Paulsen F, Bräuer L, Schicht M. Schröder H, et al. Among authors: sollfrank l. Ann Anat. 2017 Jul;212:69. doi: 10.1016/j.aanat.2017.05.004. Epub 2017 May 31. Ann Anat. 2017. PMID: 28571748 No abstract available.

5

Recombinant expression of surfactant protein H (SFTA3) in Escherichia coli.

Schröder H, Sollfrank L, Paulsen F, Bräuer L, Schicht M. Schröder H, et al. Among authors: sollfrank l. Ann Anat. 2016 Nov;208:129-134. doi: 10.1016/j.aanat.2016.05.006. Epub 2016 May 21. Ann Anat. 2016. PMID: 27221591

6

Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature.

Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M. Foerster Y, et al. Among authors: sollfrank l. Front Immunol. 2023 May 24;14:1179294. doi: 10.3389/fimmu.2023.1179294. eCollection 2023. Front Immunol. 2023. PMID: 37292193 Free PMC article. Review.

7

Case Report: The many faces of bullous pemphigoid.

Rechtien L, Sollfrank L, Foerster Y, Berking C, Sticherling M. Rechtien L, et al. Among authors: sollfrank l. Front Immunol. 2023 Oct 12;14:1272742. doi: 10.3389/fimmu.2023.1272742. eCollection 2023. Front Immunol. 2023. PMID: 37901243 Free PMC article.

8

Retrospective analysis of autoimmune bullous diseases in Middle Franconia.

Sollfrank L, Schönfelder V, Sticherling M. Sollfrank L, et al. Front Immunol. 2023 Oct 10;14:1256617. doi: 10.3389/fimmu.2023.1256617. eCollection 2023. Front Immunol. 2023. PMID: 37881435 Free PMC article.

9

Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients.

Ronicke M, Sollfrank L, Vitus MV, Walter LJ, Krieter M, Moelleken M, Dissemond J, Schultz E, Lauffer F, von den Driesch P, Erfurt-Berge C. Ronicke M, et al. Among authors: sollfrank l. Am J Clin Dermatol. 2025 Jan;26(1):139-146. doi: 10.1007/s40257-024-00904-w. Epub 2024 Nov 14. Am J Clin Dermatol. 2025. PMID: 39541069 Free PMC article.

10

Cox proportional hazards regression in small studies of predictive biomarkers.

Jóźwiak K, Nguyen VH, Sollfrank L, Linn SC, Hauptmann M. Jóźwiak K, et al. Among authors: sollfrank l. Sci Rep. 2024 Jun 20;14(1):14232. doi: 10.1038/s41598-024-64573-9. Sci Rep. 2024. PMID: 38902269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters